Modified growth hormone fusion polypeptides
US7524649B2 · kind B2 · utility
3Cited by
2References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2002 |
| Grant date | Apr 28, 2009 |
| Priority date | — |
| Expiry date | May 16, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to chimeric polypeptides wherein said polypeptides comprise a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; and tandems/oligomers of said modified growth hormone binding domains.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.